Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portal systemic encephalopathy.

J Newell

    The Nurse Practitioner
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Portal systemic encephalopathy (PSE) is a disabling neuropsychiatric disorder linked to chronic liver disease. Understanding its causes, stages, and treatments helps clinicians and patients manage symptoms effectively.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

    Physical review letters·2026
    Same author

    Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

    Physical review letters·2025
    Same author

    Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

    Physical review letters·2025
    Same author

    Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

    Physical review letters·2025
    Same author

    Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

    Physical review letters·2025
    Same author

    Supporting GPs and people with hypertension to maximise medication use to control blood pressure: a pilot cluster RCT of the MIAMI intervention.

    BMC primary care·2024
    Same journal

    Idiopathic anaphylaxis and histamine dysregulation: Revisiting pathophysiologic assumptions.

    The Nurse practitioner·2026
    Same journal

    Improving anxiety screening for adults with hypertension: An integrative review.

    The Nurse practitioner·2026
    Same journal

    Modality matters: Standard of care in telehealth.

    The Nurse practitioner·2026
    Same journal

    Updates in care for patients with genitourinary syndrome of menopause.

    The Nurse practitioner·2026
    Same journal

    Updates in care for patients with genitourinary syndrome of menopause.

    The Nurse practitioner·2026
    Same journal

    UpToDate®.

    The Nurse practitioner·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Neurology
    • Internal Medicine

    Background:

    • Portal systemic encephalopathy (PSE) is a neuropsychiatric disorder secondary to chronic liver disease.
    • Liver scarring in chronic liver disease impedes blood flow, particularly through the portal vein.
    • This leads to toxin accumulation affecting the central nervous system.

    Purpose of the Study:

    • To review the pathogenesis, stages, diagnosis, and treatment of portal systemic encephalopathy.
    • To provide nurse practitioners with comprehensive knowledge to educate patients.
    • To improve patient self-management and minimize adverse effects of PSE.

    Main Methods:

    • Literature review on portal systemic encephalopathy.
    • Analysis of disease pathogenesis and progression.

    Related Experiment Videos

  • Synthesis of diagnostic and therapeutic strategies.

    • Main Results:

    • Chronic liver disease impairs liver regeneration and causes scarring.
    • Reduced liver blood flow increases portal vein pressure, leading to collateral vessel formation.
    • Accumulated toxins in circulation cause neuropsychiatric symptoms characteristic of PSE.

    Conclusions:

    • Effective management of portal systemic encephalopathy requires concurrent treatment of the underlying liver disease.
    • Understanding PSE's mechanisms and manifestations empowers clinicians and patients.
    • Improved patient education and self-care are crucial for minimizing PSE's impact.